These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7612745)

  • 1. Toxicity following IP trimethoprim-sulfamethoxazole in a CAPD patient.
    Stamatakis MK; Sorkin MI; Moss AH
    Perit Dial Int; 1995; 15(2):180-1. PubMed ID: 7612745
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of CAPD peritonitis with oral trimethoprim/sulfamethoxazole and intraperitoneal aminoglycoside combination.
    Celik A; Cirit M; Tünger A; Akçiçek F; Basçi A
    Perit Dial Int; 1999; 19(3):284-5. PubMed ID: 10433171
    [No Abstract]   [Full Text] [Related]  

  • 3. Absorption of sulfamethoxazole and albumin from the peritoneal cavity.
    Rubin J; Planch A
    ASAIO Trans; 1990; 36(4):834-7. PubMed ID: 2268489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
    Martea M; Hekster YA; Vree TB; Voets AJ; Berden JH
    Pharm Weekbl Sci; 1987 Apr; 9(2):110-6. PubMed ID: 3495778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
    König U; Müller U; Binswanger U
    Klin Wochenschr; 1987 Jul; 65(12):562-70. PubMed ID: 3498086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapsing peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis due to Corynebacterium aquaticum.
    Morris AJ; Henderson GK; Bremner DA; Collins JF
    J Infect; 1986 Sep; 13(2):151-6. PubMed ID: 3489789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole.
    Glasson P; Favre H
    Nephron; 1984; 36(1):65-7. PubMed ID: 6606789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocardia asteroides peritonitis during continuous ambulatory peritoneal dialysis.
    Lopes JO; Alves SH; Benevenga JP; Salla A; Tatsch I
    Rev Inst Med Trop Sao Paulo; 1993; 35(4):377-9. PubMed ID: 8115800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nocardia peritonitis: satisfactory response to intraperitoneal trimethoprim-sulfamethoxazole.
    Chu KH; Fung KS; Tsang WK; Chan HW; Tong KL
    Perit Dial Int; 2003; 23(2):197-8. PubMed ID: 12713090
    [No Abstract]   [Full Text] [Related]  

  • 11. Nocardia peritonitis complicating continuous ambulatory peritoneal dialysis.
    Chan DT; Cheng IK; Chan PC; Mok KY
    Perit Dial Int; 1990; 10(1):99. PubMed ID: 2085594
    [No Abstract]   [Full Text] [Related]  

  • 12. Nocardia peritonitis -- a case report and literature review.
    Li SY; Yu KW; Yang WC; Chen TW; Lin CC
    Perit Dial Int; 2008; 28(5):544-7. PubMed ID: 18708552
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.
    Dratwa M; Glupczynski Y; Lameire N; Matthys D; Verschraegen G; Vaneechoutte M; Boelaert J; Schurgers M; Van Landuyt H; Verbeelen D
    Rev Infect Dis; 1991; 13 Suppl 7():S645-7. PubMed ID: 2068475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis.
    Halstenson CE; Blevins RB; Salem NG; Matzke GR
    Clin Nephrol; 1984 Nov; 22(5):239-43. PubMed ID: 6335067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-trimoxazole (sulphamethoxazole plus trimethoprim) peritoneal barrier transfer pharmacokinetics.
    Svirbely JE; Pesce AJ; Singh S; O'Flaherty EJ
    Clin Pharmacokinet; 1989 May; 16(5):317-25. PubMed ID: 2787223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
    Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic aspects during continuous ambulatory peritoneal dialysis: a literature review.
    Janknegt R; Koks CH
    Pharm Weekbl Sci; 1984 Dec; 6(6):229-36. PubMed ID: 6393041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous or intraperitoneal vancomycin for the treatment of continuous ambulatory peritoneal dialysis associated gram-positive peritonitis?
    Bailie GR; Morton R; Ganguli L; Keaney M; Waldek S
    Nephron; 1987; 46(3):316-8. PubMed ID: 3627326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis.
    Chenoweth CE; Robinson KA; Schaberg DR
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1800-2. PubMed ID: 2126692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of intraperitoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis.
    Tong MK; Leung KT; Siu YP; Lee KF; Lee HK; Yung CY; Kwan TH; Au TC
    J Nephrol; 2005; 18(2):204-8. PubMed ID: 15931649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.